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Abstract
Although picornaviruses provide attractive vectors for expression of foreign genes, poor genetic stability restricts their use for
immunization purposes. A new prototype vector was generated to increase foreign insert retention, by shifting of the initiation codon to a
cryptic AUG within the internal ribosomal entry site (IRES) and replacement of IRES domain VI with foreign ORFs. Using our strategy
to replace regulatory noncoding sequences with unrelated foreign genetic material, we generated stable poliovirus-based expression vectors
with robust long-term expression of foreign ORFs. Our studies revealed that size and predicted secondary structure formed by the
heterologous sequences govern long-term retention and efficiency of expression of foreign inserts replacing IRES structures. These
observations indicate that, with certain limitations imposed by structural preferences, foreign sequences can functionally replace IRES
substructures in stable picornavirus immunization vectors.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Due to the emerging threat of spreading infectious dis-
ease, either incidental or intentional, the design of novel
immunization vehicles has become an urgent priority. The
danger arising from the possibility of deliberate exposure of
populations to a wide array of infectious agents requires
flexible vaccination strategies that can be adjusted for pro-
phylaxis against a variety of agents in a short period of time.
Live-attenuated viral vaccine vectors represent a key
technology to provide the appropriate means to meet these
new challenges. Live viral vectors, manipulated through
insertion of heterologous genetic material from various
sources, can easily be directed against diverse infectious
agents. In many instances, they can be mass-produced at
low cost and generally require simple, noninvasive means of
administration.
In the recent past, a number of live-attenuated viruses
were investigated as possible immunization vectors against
infectious diseases. Among these, picornaviruses, especially
poliovirus, played a central role. The molecular biology of
picornaviruses is thoroughly understood and numerous
strategies for genetic manipulation have produced a rich
repertoire of candidate vectors (see Fig. 1). Most impor-
tantly, the success of the live-attenuated poliovirus (Sabin)
strains used for vaccination for decades indicates the poten-
tial for picornavirus-based vaccination vectors (Melnick,
1993; Gromeier et al., 1997).
Several strategies were developed to express foreign
genes or gene fragments in a picornavirus background (Fig.
1). These included minor insertions into the coding region
for the capsid proteins to display antigenic epitopes on the
surface of the viral capsid (Fig. 1B). The insert size with
capsid display vectors is limited to a few amino acids (Fig.
1B) (Burke et al., 1989; Evans et al., 1989; Arnold et al.,
1996; Halim et al., 2001). Manipulation of the capsid exte-
rior invariably is associated with decreased virus viability
and may trigger adaptation events that eliminate the foreign
insert to restore proper growth. A second strategy yielding
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replicons was based on the replacement of the structural
genes with heterologous open reading frames (ORF) (Fig.
1C) (Burke et al., 1989; Choi et al., 1991; Porter et al.,
1995). In the case of replicons, the stringent size limitations
were overcome, but resulting viruses were replication de-
fective and required capsid protein-expression systems to be
supplied in trans for vector propagation.
The third strategy generated dicistronic constructs in
which the foreign ORFs were placed under translational
control of a secondary heterologous internal ribosomal entry
site (IRES) yielding replication competent viruses with in-
dependent expression of foreign and viral genes (Fig. 1D)
(Alexander et al., 1994; Lu et al., 1995).
Most recently, polyprotein fusion vectors were devel-
oped in which the foreign ORF was linked to the viral
polyprotein with proteolytic processing provided through an
artificial cleavage site for virally encoded proteinases (Fig.
1E) (Andino et al., 1994; Tang et al., 1997; Crotty et al.,
1999, 2001).
A major limitation for use as expression vectors common
to all replication-competent ()-strand RNA viruses is their
poor genetic stability. Any attempt to achieve long-term
expression of foreign genetic material was confronted with
the phenomenon of gradual deletion of the heterologous
sequences from the viral genome in subsequent passages
(Alexander et al., 1994; Lu et al., 1995; Mueller and Wim-
Fig. 1. The genetic structure of proposed picornavirus expression vectors. The predicted secondary structure of 5- and 3-noncoding regions is indicated and
the major proteolytic products of the viral polyprotein (P1, P2, and P3) are outlined by open boxes. Solid boxes represent heterologous inserts. Engineered
proteolytic cleavage sites for the viral proteinases 2Apro and 3Cpro, respectively, are indicated by curved arrows. (A) Wild-type poliovirus. (B) Capsid display
vectors (Burke et al., 1989; Evans et al., 1989; Arnold et al., 1996; Halim et al., 2001) contain minor foreign inserts within the P1 region (coding for the
structural proteins). (C) Poliovirus replicons were generated by replacing the entire coding region for P1 with a foreign ORF (Burke et al., 1989; Choi et al.,
1991; Porter et al., 1995). (D) Dicistronic vectors. Foreign ORFs were placed under control of a secondary (encephalomyocarditis; EMCV) IRES element
and inserted between P1 and P2 (Lu et al., 1995). Alternatively, the upstream cistron is formed by the foreign ORF driven by the poliovirus IRES, and the
viral polyprotein is expressed under control of the EMCV IRES (Alexander et al., 1994). (E) Polyprotein fusion vectors. Foreign sequences were fused to
the viral ORF at its 5 terminus (Andino et al., 1994) or between the coding regions for P1 and P2 (Tang et al., 1997; Crotty et al., 1999, 2001). Both artificial
proteolytic cleavage sites for the viral 2Apro (Crotty et al., 1999, 2001) and 3Cpro (Andino et al., 1994; Tang et al., 1997; Mueller et al., 1998) proteinases
have been utilized for proteolytic processing of the fusion polyprotein.
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mer, 1998; Dufresne et al., 2002). In most instances, heter-
ologous ORFs were lost almost entirely within three gen-
erations upon replication in HeLa cells after transfection of
infectious RNA (Mueller and Wimmer, 1998; Dufresne et
al., 2002).
Attempts to increase genetic stability by varying the
insertion locale did not significantly alter retention rates of
foreign ORFs. Dicistronic and polyprotein fusion vectors
have been generated that contain foreign inserts either fused
N-terminally to the viral polyprotein (Figs. 1D and E) (Al-
exander et al., 1994; Andino et al., 1994), or separating P1
and P2 (Figs. 1D and E) (Lu et al., 1995; Tang et al., 1997;
Crotty et al., 1999, 2001).
Here we are proposing a new approach to generate po-
liovirus-based expression vectors for immunization pur-
poses. Our strategy includes fusion of foreign ORFs to the
viral polyprotein through artificial proteolytic cleavage sites
(proposed earlier by Andino et al., 1994). However, instead
of merely adding foreign sequences to the viral genome, we
designed inserts to functionally replace a structural element
contained within the IRES. Our strategy to favor retention
of heterologous genetic material through strategic place-
ment within a noncoding regulatory element produced ex-
pression vectors with improved genetic stability replicating
with near wild-type kinetics in HeLa cells. Moreover, we
have identified the size limitations and structural require-
ments for long-term retention and efficient expression of
foreign inserts in picornaviral expression vectors with re-
combinant IRES elements.
Results
PVS-RIPO, a highly attenuated chimeric virus contain-
ing the human rhinovirus type 2 (HRV2) IRES in a polio-
virus type 1 (Sabin) [PV1(S)] background (Gromeier et al.,
1996), was used as the backbone vector to generate polio-
virus-based expression constructs. We chose this chimeric
virus for our studies because evaluation of neurovirulence
of PV1(RIPO) [in a poliovirus type 1 (Mahoney) back-
ground] in nonhuman primates revealed levels of attenua-
tion equal to PV1(S) (Gromeier et al., 1999). These obser-
vations indicated that attenuation of neurovirulence of PVS-
RIPO [containing attenuation determinants mapping to the
coding region for the structural gene products and the RNA
polymerase 3Dpol (Gromeier and Nomoto, 2002) in addition
to the attenuating effect of the HRV2 IRES] may be supe-
rior to that of PV1(S). Comprehensive neurovirulence as-
sessment of PVS-RIPO in nonhuman primates is scheduled
to begin in the near future. Moreover, unlike the Sabin
vaccine strains, the attenuation phenotype of PVS-RIPO is
remarkably stable upon passage in cell lines of neuronal
derivation or mice transgenic for the human poliovirus re-
ceptor (Gromeier et al., 1996, 2000).
We have used a new approach for the construction of
fusion polyprotein expression vectors to increase long-term
retention and expression of foreign sequences. Rather than
inserting foreign sequences into the intact poliovirus ge-
nome, we replaced parts of the HRV2 IRES with heterolo-
gous ORFs of varying size. IRESs of all picornaviruses
feature highly conserved structure elements predicted to
form stable stem-loop domains (Pilipenko et al., 1989a,
1989b; Skinner et al., 1989). These predicted hairpin struc-
tures are separated by linear sequence motifs that may
display a surprising level of sequence conservation among
picornaviruses. For example, a six-nucleotide stretch sepa-
rating stem-loop domains IV and V is highly conserved
throughout the enterovirus and rhinovirus genera and is
absolutely required for IRES function (Belov et al., 1995).
The most thoroughly studied sequence motif within pi-
cornavirus IRES elements is a conserved linear polypyrimi-
dine stretch located in between stem-loop domains V and VI
(Fig. 2) (Iizuka et al., 1989; Meerovitch et al., 1991; Pestova
et al., 1991; Pilipenko et al., 1992; Wimmer et al., 1993).
The Y(n)X(m)AUG motif contains a cryptic AUG codon
that is never used to initiate translation (Pestova et al., 1991;
Wimmer et al., 1993). Instead, an AUG triplet located 33 nt
(HRV2) or 155 nt (poliovirus) downstream of Y(n)X-
(m)AUG serves as initiation codon for the viral polyprotein
synthesis (Fig. 2A). It has been previously shown for po-
liovirus (Pestova et al., 1994) that initiation of translation
can be moved to Y(n)X(m)AUG by altering the context of
its AUG triplet. We deleted stem-loop domain VI of the
HRV2 IRES and placed the Y(n)X(m)AUG in Kozak con-
text (Fig. 2B; Kozak, 1999). This manipulation yielded a
viable virus, RP6, which exhibited replication kinetics in
HeLa cells similar to the parental PVS-RIPO virus (Fig.
2C), suggesting that deletion of IRES domain VI only had
a minor effect on virus growth.
RP6 was used as the backbone vector to generate po-
liovirus-based expression constructs with heterologous
ORFs (Fig. 3). Foreign genes were inserted immediately
downstream of the Y(n)X(m)AUG motif, which supplied
the initiation codon for the fusion polyprotein (Fig. 3A).
The sequence encoding the N-terminal four amino acids of
the polioviral polyprotein (MGAQ. . .) was placed at the 5
junction of the expression cassette to ensure proper process-
ing of the fusion polyprotein (Fig. 3A). The 3 junction of
the foreign insert and the polioviral ORF contained the
sequence encoding an artificial cleavage site for the viral
proteinase 2A (2Apro; . . .KGLTTY’G. . .; Fig. 3A) (Andino
et al., 1994; Crotty et al., 1999). Thus, posttranslational
proteolytic cleavage of the fusion polyprotein was predicted
to release foreign and viral polypeptides without impedi-
ment to virus viability.
A series of expression constructs were generated to eval-
uate our approach. First, we tested the influence of insert
size on genetic stability (Fig. 3). For this purpose, RP6
expression vectors containing inserts encompassing the
ORFs of a bacterial antigen (a portion of Escherichia coli
FimH; 102 nt), the human immunodeficiency virus tat pro-
tein (HIVtat; 282 nt), simian immunodeficiency virus matrix
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protein (SIVp17; 420 nt), and the enhanced green fluorescent
protein (EGFP; 744 nt), respectively, were generated (Figs.
3A–D). The insert length indicated comprises sequences
coding for the leader peptide and the artificial proteolytic
cleavage site in addition to the foreign ORF.
The 5-terminal sequences of the foreign inserts in RP6-
FimH, RP6-HIVtat, and RP6-EGFP were modified by
silent mutagenesis to form a predicted stable stem-loop
structure in a position equal to HRV2 IRES domain VI (see
sequence detail in Figs. 3A, B, and D). RP6-SIVp17, by
virtue of the presence of the “AUG” loop in the SIV 5
leader (Berkhout, 1996), naturally formed a stable stem-
loop structure reminiscent of the HRV2 IRES domain VI
(Fig. 3C).
All four expression constructs produced viable viruses,
but insert retention through serial passages in HeLa cells
varied dramatically (Figs. 3A–D). Whereas RP6-FimH
(102 nt insert) and RP6-HIVtat (282 nt insert) retained the
full-length insert throughout at least 20 subsequent passages
(Figs. 3A and B), expression constructs containing larger
foreign ORFs were less stable. Serial passage of RP6-
SIVp17 (420 nt insert) revealed the emergence of deletion
variants nine passages after transfection, and foreign se-
quences within RP6-EGFP (744 nt insert) were deleted
already during the first passage (Fig. 3D).
The evaluation of long-term insert retention of all ex-
pression vectors by RT-PCR analysis was complemented by
plaque assays of each individual passage. Apart from the
results of RT-PCR analysis, deletion events after passaging
of RP6-SIVp17 and RP6-EGFP were also evident by the
emergence of large-plaque variants. In contrast, the plaque
phenotype of the stable RP6-FimH and RP6-HIVtat re-
mained constant throughout 20 passages (data not shown).
Our observations may indicate that, within limits, polio-
virus expression vectors can be designed to retain foreign
ORFs using integration of heterologous inserts into 5 reg-
ulatory elements. Furthermore, our experiments suggest in-
serts  300 nt in length may exceed the size restraints
imposed by the location of the insert and may trigger dele-
tion events.
To ascertain whether insert retention correlated with the
size of the foreign ORF alone, we constructed RP6-
SIVp17(282) and RP6-EGFP(282) (Fig. 4). In both con-
structs the insert size was adjusted by C-terminal deletion of
the foreign ORF to correspond to that of the genetically
stable RP6-HIVtat(282). Apart from the shortened foreign
insert, the genetic structure of RP6-SIVp17(282) and RP6-
EGFP(282) was identical to the unstable RP6-SIVp17(420)
and RP6-EGFP(744) (compare Figs. 3C and D and Figs.
4A and B). The diminished size of the foreign inserts re-
sulted in increased genetic stability, evident by complete
insert retention after 20 passages (Fig. 4). Our observations
Fig. 2. Genetic structure and growth properties of PVS-RIPO and a deletion variant. (A) PVS-RIPO contains a full-length HRV2 IRES element. The
polypyrimidine tract [Y(n)], separating stem-loop domains V and VI, is underlined. The conserved cryptic AUG is indicated by asterisks and separated from
Y(n) by a spacer [X(m)]. Initiation of translation occurs at an AUG codon (bold) located 33 nt downstream of the cryptic AUG within Y(n)X(m)AUG. (B)
In the deletion mutant (RP6), the sequence of X(m) was altered to incorporate a restriction site for endonuclease BglII and to place the cryptic AUG in Kozak
context (. . .cuuaugg. . . to accaugg. . .). The remainder of IRES domain VI was deleted and translation in RP6 started from Y(n)X(m)AUG. (C) Comparison
of the growth properties of the parental PVS-RIPO (open diamonds) with those of RP6 (open squares) in HeLa cells in one-step growth curves.
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confirmed that insert size was the cardinal determinant of
foreign ORF retention.
Despite the diminished genetic stability of RP6-SIVp17
and RP6-EGFP, our approach produced prototype expres-
sion vectors that exhibited far superior retention of foreign
ORFs than previously reported strategies to generate
polyprotein fusion vectors. These vectors, independently of
insert size, are characterized by a high degree of genetic
instability (Mueller and Wimmer, 1998). This was also
evident when we constructed “conventional” polyprotein
fusion vectors using a blueprint proposed by Andino et al.
(1994). Vectors containing a 420-nt SIVp17 insert equal to
RP6-SIVp17 fused to the poliovirus ORF and containing
the entire IRES element deleted foreign sequences within
one to two passages (Dufresne et al., 2002).
Next, we evaluated the influence of predicted secondary
structure on insert retention of RP6 expression vectors.
Since part of our strategy is based on the functional replace-
ment of IRES stem-loop domain VI, the secondary structure
assumed by the foreign insert is likely to influence IRES
function and, therefore, insert retention. We chose RP6-
SIVp17 to alter the predicted stability of the artificial stem-
loop domain VI formed by heterologous sequences (Fig. 5).
The initiating AUG codon of SIVp17 is located within the
AUG loop of the SIV leader in a position similar to that of
the cryptic AUG within the Y(n)X(m)AUG motif of picor-
Fig. 3. Genetic structure and stability of RP6-based expression vectors with foreign inserts of different sizes. The general architecture of these expression
vectors is exemplified by RP6-FimH (A). Foreign sequences are inserted in a position to emulate stem-loop domain VI of the HRV2 IRES. The position
and amino acid sequence of an artificial cleavage site for 2Apro is indicated. The polioviral ORF is represented by a black box. The sequence detail represents
the 5 termini of each of the foreign inserts forming a predicted artificial stem-loop structure replacing IRES domain VI, as shown. The location of the
initiating AUG within Y(n)X(m)AUG and the position of the leader peptide are identical in all constructs. The total lengths of the foreign inserts, including
sequences of the leader peptide and the artificial proteolytic cleavage site, are shown in bold. The results of RT-PCR analysis of total cellular RNA from
infected cultures in serial passages are shown on the right. Labeling of the agarose gels corresponds to the origin of the total RNA preparation subjected to
RT-PCR analysis (P plasmid DNA of the corresponding expression construct; T RNA isolated from HeLa cells transfected with in vitro transcript; 1–15
 individual virus passages; RP6  plasmid DNA of the backbone construct without any foreign insert; M  molecular weight marker). Arrowheads
indicate amplicons corresponding to the full-length inserts. (A) RP6 expressing a portion of the bacterial adhesion molecule FimH. (B) RP6 expressing
the HIV-1 tat protein. (C) RP6 expressing the SIV matrix protein (SIVp17). (D) RP6 expressing the enhanced green fluorescent protein (EGFP).
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naviruses (Fig. 5A, compare Fig. 2A). Two expression vec-
tors (RP6-SIVp17-acc and RP6-SIVp17-aag) were con-
structed differing only in the sequence of two nucleotides
immediately upstream the initiating AUG codon (. . .ac-
caugg. . . vs . . .aagaugg. . .) (Fig. 5). Both sequences
placed the initiating codon in Kozak context and maintained
the predicted overall structure of the AUG loop. However,
in the RP6-SIVp17-acc construct, the ACC triplet disrupted
base-pairing that was predicted to increase the stability of
the stem-loop formed by SIVp17 sequences in the RP6-
SIVp17-aag construct (Figs. 5A and C).
After transfection of HeLa cells with in vitro RNA tran-
Fig. 4. Genetic structure of RP6-SIVp17(282) (A) and RP6-EGFP(282) (B), containing C-terminal truncated versions of the full-length SIVp17 and EGFP
ORFs. The right-hand panel shows the results of RT-PCR analysis of total RNA isolated from serial passages of both constructs in HeLa cells. Arrowheads
indicate the amplification product from the full-length expression vector constructs.
Fig. 5. Effect of the predicted secondary structure of the artificial stem-loop domain VI on insert retention in RP6-SIVp17. The general architecture of
expression construct RP6-SIVp17 is shown in more detail in Fig. 3. The modified predicted stem-loop structure of the SIV “AUG” loop in RP6-SIVp17-acc
is shown [compare (A) and (C)]. The free energy of the AUG loop formation in constructs RP6-SIVp17-aag (G  9.6 kcal/mol) and RP6-SIVp17-acc
(G  3.5 kcal/mol) was calculated using the Mfold 3.1 algorithm (Zuker et al., 1999). Genetic stability and insert retention was analyzed by RT-PCR
of total RNA isolated from serial passages of the corresponding virus. The labeling of lanes in the agarose gels is as shown in Fig. 3. Arrowheads point toward
the full-length SIVp17 insert. (A) Serial passaging of RP6-SIVp17-aag yielded a number of deletion variants by the 9th passage. (B) SIVp17 could be detected
by Western blot of infected cell lysates up to the 12th passage (arrowhead). (C) Deletion of foreign insert was significantly accelerated by the decreased
predicted stability of the SIV AUG loop in RP6-SIVp17-acc.
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scripts, we recovered viruses that were subjected to serial
passages in HeLa cells. Total cellular RNA was isolated
from each infected culture and analyzed by RT-PCR with
virus-specific primers encompassing the IRES and SIVp17
insert (Fig. 5).
RT-PCR analysis revealed a significantly decreased re-
tention of the foreign ORF in RP6-SIVp17-acc, due to the
minor alteration resulting in weakening of the recombinant
stem-loop domain VI (Fig. 5C). RP6-SIVp17-acc displayed
deletions of SIVp17 sequences already after the first passage
after transfection (Fig. 5C). Within two passages the intact
foreign insert could no longer be detected by RT-PCR of
total RNA isolated from infected cells (Fig. 5C). In contrast,
RP6-SIVp17-aag, merely differing by a slightly more stable
stem-loop structure, retained the intact SIVp17 insert for at
least eight subsequent passages (Fig. 5A). Western blot
analysis of cell lysates from consecutive passages of RP6-
SIVp17-aag was consistent with RT-PCR data revealing
SIVp17 expression in tandem with insert retention (Fig. 5B).
SIVp17 expression was detected until the 12th passage,
when full-length insert could barely be detected by RT-PCR
analysis (compare Figs. 5A and B).
Eventually, several deletion mutants emerged with the
9th passage of RP6/SIVp17-aag and after the 12th passage,
full-length insert could no longer be detected by RT-PCR.
From the 15th passage on, a sole amplification product
remained, retaining 126 nt (30%) of the original insert.
Our observations, indeed, suggested that secondary
structure of foreign sequences inserted to replace IRES
domain VI might influence the genetic stability of RP6
expression vectors. Constructs with foreign inserts pre-
dicted to form stable secondary structure mimicking the
architecture of IRES domain VI could have advantages over
nonstructured inserts with regard to retention of heterolo-
gous sequences.
To corroborate this hypothesis, we modified the pre-
dicted stability of stem-loop structures formed by poliovirus
expression vectors with stably retained inserts. For this
purpose we chose RP6-HIVtat, stably retaining a 282-bp
foreign insert for at least 20 passages (Fig. 3B). Three
expression vectors, RP6-HIVtat(1)–(3), were constructed
that contained inserts differing in the predicted stability of
the artificial domain VI stem-loop formed by sequences
coding for HIVtat (Figs. 6 and 7).
The RP6-HIVtat(1) and RP6-HIVtat(2) constructs with
strong and moderately strong secondary structures forming
stem-loop domain VI (G  26.9 and 8.0 kcal/mol,
respectively, Figs. 6A and B), were stable throughout at
least 20 serial passages. A single amplification product
corresponding to the full-length HIVtat insert was detected
Fig. 6. Genetic stability of RP6-HIVtat(1) and RP6-HIVtat(2) expression vectors. The general architecture of RP6-HIVtat is shown in detail in Fig. 3. The
sequence of HIVtat was modified through silent mutagenesis to form a strong (A; G  26.9 kcal/mol) or a moderately strong (B; G  8.0 kcal/mol)
stem-loop structure in place of IRES domain VI. Sequence modifications designed to lessen the predicted stability of the artificial stem-loop domain VI did
not affect the position of the initiating AUG, the leader peptide, or the overall size of the insert. RT-PCR analysis of serial passages of RP6-HIVtat(1) and
RP6-HIVtat(2) viruses in HeLa cells is shown on the right (labeling corresponds to the legend in Fig. 3). Arrowheads indicate the amplicon corresponding
to a full-length HIVtat insert. (C) Western blot analysis of cell lysates from serial passages of RP6-HIVtat(1) virus with HIVtat-specific antibodies (the
arrowhead indicates HIVtat).
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by RT-PCR in all passages (Figs. 6A and B). Accordingly,
Western blot analysis revealed solid expression of HIVtat in
infected cell lysates collected from consecutive passages
(Fig. 6C).
In contrast, RP6-HIVtat(3) (stem-loop VI, G  6.5
kcal/mol) acquired deletions in the HIVtat insert already
after the third passage (Fig. 7A). Notwithstanding the ap-
pearance of deletion variants, full-length insert could still be
detected after 20 passages (Fig. 7A). Surprisingly, upon
appearance of deletion variants, we also detected a variant
containing an enlarged insert, emerging after the 11th pas-
sage of RP6-HIVtat(3) in HeLa cells (Fig. 7A). RT-PCR
data indicated that the enlarged variant rapidly became
predominant in the viral population, evident from the rela-
tive intensities of the amplification products. This finding
suggested a beneficial effect of insert enlargement leading
to increased fitness over RP6-HIVtat(3) and its deletion
variants.
Sequencing of deletion variants emerging upon serial
passages of RP6-HIVtat(3) revealed a 108-nt internal de-
letion within the ORF for HIVtat. This deletion retained all
but a remnant stem-loop structure VI (Fig. 7B). Interest-
ingly, sequencing of the enlarged RP6-HIVtat(3) variant
(Fig. 7C) revealed replacement of an internal fragment of 84
nt of the HIVtat ORF with a 129-nt duplication of viral
coding sequences for the capsid protein VP1 (nt 2986–
3115). These observations conflicted with the expectation of
foreign inserts to be deleted to restore efficient growth.
Our observations indicated that foreign sequences in-
serted strategically to functionally replace secondary struc-
tures within the IRES element might be indefinitely retained
by replicating virus. These data suggest that high retention
rates are achieved because foreign sequence inserts do not
either interfere with or even exert beneficial effects on
efficient virus propagation. We therefore examined the
growth kinetics of a prototype stable poliovirus-based ex-
pression vector, RP6-HIVtat(2), and compared the relative
rates of viral gene expression and foreign insert expression
(Fig. 8).
Comparative one-step growth curves of RP6-HIVtat(2)
and its parent RP6 demonstrated viral growth rates slightly
accelerated with the former (Fig. 8A). The analysis of for-
eign gene expression with HIVtat-specific antibodies re-
vealed high expression rates of the foreign insert in step
with those of cognate viral gene products (Fig. 8B). The
data shown demonstrated efficient synthesis of the fusion
polyprotein containing the foreign ORF and uninhibited
proteolytic processing at the artificial 2Apro site (no un-
processed precursors of the foreign gene product were de-
tected).
Viral gene expression of RP6-HIVtat(2), measured
through detection of the viral nonstructural protein 2C and
its proteolytic precursors P2 and 2BC (Fig. 8B), occurred
earlier than with RP6. Initial viral gene expression of
RP6-HIVtat(2) was detected already at 3 h p.i., whereas
RP6 translation occurred with 1 h delay (Fig. 8B).
These observations indicated that, indeed, insertion of
foreign sequences in place of HRV2 IRES stem-loop do-
Fig. 7. Genetic stability of RP6-HIVtat(3). (A) The predicted stability of the artificial stem-loop structure formed by HIVtat sequence in RP6-HIVtat(1), and
(2) was further lowered by silent mutagenesis to yield RP6-HIVtat(3) (G  6.5 kcal/mol). RT-PCR analysis of serial passages of RP6-HIVtat(3) virus
in HeLa cells revealed rapid deletion of the foreign insert and the emergence of an enlarged variant (the full-length unaltered insert is indicated by an
arrowhead). (B) Genetic structure and sequence of a deletion variant of RP6-HIVtat(3) isolated at the 10th passage. (C) Genetic structure and sequence of
an enlarged RP6-HIVtat(3) variant isolated at the 20th passage.
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main VI confers a growth advantage to RP6-HIVtat(2).
This beneficial effect on viral gene expression may explain
long-term retention of foreign sequences in genetically sta-
ble picornavirus expression vectors with recombinant IRES
elements.
Discussion
Picornaviruses, despite their genetic austerity, devote
almost 10% of their coding capacity to the IRES element.
These complex, highly structured genetic elements are
known to mediate cap-independent initiation of translation
(Jang et al., 1988, 1989; Pelletier et al., 1988; Pelletier and
Sonenberg, 1988) but also are likely to participate in other
functions, e.g., genome replication (Borman et al., 1994).
Structural complexity has hampered efforts to elucidate
the functional significance of IRES structure and basic
mechanisms of translational initiation at the IRES element.
Studies of the effect of mutations on IRES function helped
to outline sequence motifs exquisitely sensitive to sequence
alterations (Pestova et al., 1991; Belov et al., 1995), but did
little to increase our knowledge of basic IRES function.
Researchers are faced with the dilemma of a complex three-
dimensional structure that may be affected by sequence
modification in unforeseen ways.
Picornavirus IRESs have been divided into type 1 (en-
tero-, rhinovirus) and type 2 (aphtho-, hepato-, cardiovirus)
(reviewed in Wimmer et al., 1993). All type 1 IRESs are
structurally highly related with the exception of the 3-most
portion. Enteroviruses contain a stretch (124–155 nt in
length) of predicted unstructured sequence separating stem-
loop domain VI from the initiating AUG. Rhinovirus IRES
elements lack this “spacer” and, instead, initiate translation
from an AUG at the base of stem-loop domain VI (see Fig.
2). The functional significance of the spacer region for
enteroviruses is unknown. Deletion of this spacer had no or
only negligible effect on poliovirus replication rates in
HeLa cells and pathogenicity (Kuge and Nomoto, 1987).
Notwithstanding the empirical observations stemming from
deletion experiments, the fact that all enteroviruses retain a
lengthy spacer region to separate stem-loop domain VI from
the initiating AUG may indicate that it is beneficial to virus
propagation.
Our observations confirm this assumption, supported by
data that showed RP6-HIVtat(3) virus to acquire a 129-nt
insert within the foreign ORF derived of viral sequences
coding for VP1 upon serial passages in HeLa cells. Acqui-
sition of added sequence, a rare event in ()-strand RNA
viruses keen on minimizing the length of their genomes,
may indicate an increase in viral fitness due to this event.
We speculate that a certain structural arrangement surround-
ing the conserved cryptic AUG (used as initiation codon in
our vectors) and the true initiation codon (153 nt down-
stream of the cryptic AUG in poliovirus) promotes transla-
tional initiation. Our data suggest that genetic manipulations
which disturb this arrangement, for example, foreign inserts
in between both AUG triplets, may trigger adaptation
events, e.g., acquisition of added sequences, to restore the
preferred structure. Analyses of the secondary structure of
added sequences in the enlarged variant of RP6-HIVtat(3)
did not reveal a particular arrangement favored by replicat-
ing virus.
Given the intricate relationship of IRES structure and
function, we were surprised to observe that substantial al-
terations of IRES composition, the replacement of an entire
stem-loop structure with totally unrelated foreign se-
quences, were readily tolerated by poliovirus. Our observa-
tions indicate that, within limits, the function of certain
Fig. 8. Comparative rates of virus growth and gene expression in HeLa cells infected with RP6 and RP6-HIVtat(2), respectively. At the indicated time points
[(0, 2, 3, 4, 5, 6, 7, and 8 h postinfection (p.i.)] infection was interrupted and freeze-thawed cell lysates were subjected to plaque assay or Western blot analysis
as described under Materials and methods. (A) One-step growth kinetics of RP6 (open diamonds) and RP6-HIVtat(2) (open squares). (B) Western blot
analysis of RP6 (top) and RP6-HIVtat(2) (middle) with monoclonal antibodies against the poliovirus P2/2BC/2C gene products. The bottom represents
Western blot analysis of RP6-HIVtat(2) with polyclonal antibodies directed against the HIV-1 tat protein. Arrowheads indicate the viral gene products P2,
2BC, and 2C and the HIV-1 tat protein.
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regions of the IRES may be maintained by structurally
related sequence elements with heterologous sequence.
This principle can be exploited for the construction of
genetically stable picornavirus expression vectors. In these
vectors, foreign ORFs are retained by replicating virus to
functionally replace 5 noncoding sequences. This vector
design bears resemblance to the context of the IRES of
hepatitis C virus (HCV). Sequences coding for the HCV
core protein located immediately downstream of the initia-
tion codon have been reported to strongly influence IRES
function (Lu and Wimmer, 1996; Wang et al., 2000). The
influence of core coding sequences on HCV IRES function
has been ascribed to structural formations within the core
sequence rather than its translation product (Wang et al.,
2000).
Attempts to utilize plus-strand RNA viruses for the con-
struction of immunization vehicles, despite their many ad-
vantages for vector design and antigen delivery, were con-
sistently plagued by poor retention of foreign inserts. A
number of strategies have been proposed to increase the
stability of picornaviral expression vectors, e.g., varying the
location of the inserted foreign ORF (see Fig. 1). However,
the inherent genetic variability of picornaviruses will pre-
vent any attempt to achieve permanent retention of foreign
genetic material by simply adding it to the viral genome.
We currently do not understand the exact structural re-
quirements for efficient initiation of translation at the picor-
naviral IRES element. This is particularly true for the 3-
most IRES region adjacent to the initiation site, containing
highly conserved sequence motifs essential for IRES func-
tion and harboring areas of diversity that distinguish IRES
elements from different picornavirus genera. However, the
apparent high degree of genetic plasticity and the virus’
preference for a certain structural arrangement within this
region open up a unique opportunity to generate genetically
stable picornavirus expression vectors. Integrating foreign
ORFs into the IRES element to assume regulatory functions
benefiting virus replication may force picornaviruses to per-
manently retain these sequences within their genomes. This
new strategy may find applicability in the design of novel
picornavirus-based expression vectors for immunization
purposes. We are currently investigating our novel vector
prototype for vaccination purposes in experimental animals.
Materials and methods
Cloning of foreign ORF into polioviral expression vector
Construction of the recombinant plasmid expressing for-
eign ORF was performed in the background of a PVS-RIPO
cloning cassette (Gromeier et al., 1996) in which the HRV2
IRES was flanked by unique restriction sites EcoRI and
SacI. The HRV2 IRES fragment lacking domain VI (IRES-
6) was generated through PCR with the Expand High
Fidelity PCR System (Roche) using primers (1) 5-GGGAAT-
TCACTTAGAAGTTTTTCAC-3 and (2) 5-GGAGATCTA-
AAGGAAAAAGTGAAACACGG-3 and PVS-RIPO as tem-
plate.
An antigenic determinant of a bacterial adhesion molecule,
FimH, was PCR-amplified with primers (3) 5-GAAGATCT-
GACCATGGGCGCGCAGTGTAAAACCGCCAATGGT-
ACC-3 and (4) 5-CCGAGCTCCATATGTTGTGAGAC-
CTTTGACGGGCGCAAGGTTTAC-3 The PCR fragments
were digested with EcoRI and BglII (IRES segment) or BglII
and SacI (the FimH fragment) and ligated into PVS-RIPO cut
with EcoRI and SacI to yield RP6-FimH.
RP6-HIVtat(1), RP6-HIVtat(2), and RP6-HIVtat(3)
were constructed as follows: the fragments encoding for
HIVtat were PCR-amplified from a full-length HIV-1LAI
proviral clone (obtained from the NIH AIDS reagent and
reference program) with forward primers (5) 5-AAGGGC-
CCAGGAGCCAGTAGATCCTAGACTAGAGCCCTGG-
AAGCACCCAGGGTCACAGCCT-3 [RP6-HIVtat(1)], (6)
5-CCGGGCCCAGGAACCAGTCGATCCTAGACTAG-
AGCC-3 [RP6-HIVtat(2)], or (7) 5-GGAGATCTGAA-
GATGGGAGCACAAGAACCAGTAGATCCAAGACTA-
GAGCCATGGAAGCACCCCGGAAGTC-3 [RP6-HIVtat(3)]
and the reverse primer (8) 5-GGGAGCTCCATATGTT-
GTGAGACCTTTTTCCTTCGGGCCTGTCGG-3. The
IRES-6 segment for RP6-HIVtat(1) and RP6-HIVtat(2)
was generated with primers (1) and (9) 5-CTGGGC-
CCCCATGGTCAGATCTAAAGGAAAAAGTGAAACA-
CG-3 and ligated with the corresponding HIVtat fragments
through an ApaI restriction site. The IRES-6 fragment for
RP6-HIVtat(3) was produced with primers (1) and (2) us-
ing a BglII site for the junction with the HIVtat fragment.
RP6-SIVp17-acc and RP6-SIVp17-aag, containing the
ORF for SIVp17, were PCR-amplified from full-length
cDNA for SIVmac239 (kindly provided by L. Alexander)
with the forward primers (10) 5-GGAGATCTGACCAT-
GGGCGCGCAAAACTCCGTCTTGTCAGGG-3 or (11)
5-GGAGATCTGAAGATGGGCGCGCAAAACTCCGTC-
TTGTCAGGG-3 and reverse primer (12) 5-CCGAGCTC-
CATATGTTGTGAGACCTTTGTAATTTCCTCCTCTGC-
CGC-3 and cloned into PVS-RIPO along with the IRES-6
fragment generated with primers (1) and (2). RP6-
SIVp17(282) was generated by PCR amplification of a C-
terminally truncated SIVp17 fragment using primers (11)
and (13) 5-GGGAGCTCCATATGTTGTGAGACCTTT-
GATGACGCAGACAGTATTATAAAGG-3 and inserted
into PVS-RIPO as described for the full-length SIVp17 frag-
ment.
RP6-EGFP was generated by PCR amplification of the
insert from pEGFP-N1 (Clontech Laboratories, Inc.) with
primers (14) 5-CCGTGCACAGGTCTCCAAGGGAGAG-
GAGCTGTTC-3 and (15) 5-GGGAGCTCCATATGTT-
GTGAGACCTTTCTTGTACAGCTCGTCCATGC-3. For
this expression vector, domains II–V of the HRV2 IRES
were amplified with primers (1) and (16) 5-CCGTGCAC-
CCATGTTCAAATATAAAGGAAAA-3. The ligation of
the IRES6 and EGFP fragments was accomplished through
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an ApaLI site introduced by a silent mutation. The truncated
EGFP fragment in RP6-EGFP(282) was PCR-amplified
using primers (14) and (17) 5-GGGAGCTCCATATGTT-
GTGAGACCTTTGAAGAAGTCGTGCTGCTTC-3 and
inserted into PVS-RIPO as described.
Recovery of infectious virus and passaging
Recombinant plasmids containing viral cDNA were di-
gested at a unique AviII site, purified using a PCR Purifi-
cation Kit (Qiagen), and used as templates for in vitro
transcription that was performed with T7 RNA polymerase
(Stratagene) as described before (Gromeier et al., 1996).
RNA from in vitro transcription reactions was quantified
through parallel agarose gel electrophoresis with a quanti-
tation standard (Invitrogen). The integrity of transcript RNA
was determined through analytic gel electrophoresis in
0.7% agarose, 6% formaldehyde, 1 MOPS buffer (0.1 M
MOPS, pH 7.0, 40 mM sodium acetate, 5 mM EDTA).
Transcript RNA was used at a concentration of 2 pg/cell for
transfection experiments. These were carried out by adding
the appropriate amount of RNA transcript to 5  105 HeLa
R19 cells using DMRIE-C Reagent (Gibco) following the
manufacturer’s instructions. Two days posttransfection, the
cells were lysed by two freeze-thaw cycles to produce initial
viral stocks.
The recovered virus stocks were subjected to 20 subse-
quent passages in HeLa cells. For this purpose, the original
stock and all subsequent passages were subjected to plaque
analysis to determine the viral titer. All passages with all
expression constructs were carried out at a multiplicity of
infection (m.o.i.) of 5. Briefly, 90% confluent cell mono-
layers (8  105 cells) were incubated with the viral stock
at an m.o.i. of 5 for 30 min at room temperature. Then cells
were overlaid with growth medium containing 2% FBS and
incubated at 37°C for 24 h; following this incubation period,
complete CPE had occurred in all passages conducted. In-
fected cells were lysed by two freeze-thaw cycles. The cell
lysate was divided, subjected to plaque assay analysis, and
used to establish infection of a fresh cell culture and to
collect total cellular RNA for further analysis by RT-PCR.
All transfections and subsequent passaging series were per-
formed in duplicate.
RT-PCR analysis of RNA from infected cells
The genetic stability of viruses expressing foreign ORFs
was analyzed by reverse transcription–PCR (RT-PCR) of
total cellular RNA preparations from infected cell lysates.
Total cellular RNA from infected HeLa lysates was isolated
using Trizol reagent (Gibco-BRL). Reverse transcription of
viral RNA was performed with StrataScript RT Kit (Strat-
agene) or M-MLV reverse transcriptase (Gibco-BRL) fol-
lowing the manufacturer’s instructions. RT reactions were
carried out using poliovirus type 1 specific primer (18)
5-CATGTGCGCCCACTTTCTGTG-3 complementary to
the sequences coding for the capsid protein VP4, immedi-
ately downstream of the artificial cleavage site for 2Apro,
separating the foreign ORF from the viral polyprotein. After
incubation for 1 h at 42°C, the RT reactions were terminated
by incubation for 3 min at 95°C and resulting cDNA was
PCR amplified with primers (18) and (19) 5-CGCCT-
GTTTTATACTCCCTTCCC-3 (annealing to sequences
upstream of the IRES element within the cloverleaf) using
Taq DNA polymerase (Promega).
One-step virus growth curves
One-step virus growth curves were performed as de-
scribed in Gromeier et al. (1996). Briefly, HeLa cell mono-
layers were incubated and gently rocked for 30 min at room
temperature with virus to be tested suspended at an m.o.i. of
10. Thereupon, monolayer cultures were thoroughly rinsed
three times to remove unbound virus and subsequently
placed at 37°C for specified periods. Thereafter, the cultures
were frozen and treated for further testing by plaque anal-
ysis. A 0 h sample, reflecting the portion of virus bound to
the cells, was frozen immediately upon removal of unbound
particles.
Western blotting
Western blot analysis was used to evaluate foreign gene
expression and to compare the relative rates of polioviral
and foreign protein synthesis in HeLa cells. Cell monolayers
were incubated with virus to be tested at a multiplicity of
infection of 10 for 30 min at room temperature. Afterward,
cells were washed from unbound virus, overlaid with
growth medium containing 2% FBS, and placed at 37°C. At
the specified time points infection was interrupted, cells
were washed with PBS and lysed with 0.1 ml of SDS–
PAGE sample buffer (Invitrogen). Lysed samples (5–10 l
of cell lysate) were resolved by electrophoresis in a 4–12%
Bis–Tris NuPAGE Gel (Invitrogen) and transferred to PRO-
TRAN nitrocellulose membrane (Schleicher & Schuell) fol-
lowing standard procedures. After blocking with 3% nonfat
milk in TBST (100 mM Tris, 150 mM NaCl, 0.05% Tween
20, pH 8.0) for 1 h, membranes were incubated with pri-
mary antibodies. For assays of viral gene expression, an
anti-2BC/2C monoclonal antibody (kindly provided by E.
Wimmer) was employed. A polyclonal anti-HIVtat antibody
(kindly provided by B. Cullen), and hyperimmune sera from
rhesus macaques infected with SHIV were used for the
Western blot detection of HIVtat and SIVp17, respectively.
Following three washes with TBST, membranes were
treated with secondary biotinylated antispecies antibody
(Vector Labs), rinsed again, and finally developed with
streptavidin-horseradish peroxidase (POD) conjugate
(Roche) and visualized with POD-blue substrate (Roche) or
ECL Western blotting detection reagents (Amersham).
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